(NASDAQ:IBIO), SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) — iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that it has entered into a securities purchase agreement with existing healthcare-focused, high-quality institutional investors for a private placement (“PIPE”) financing that is expected to result in gross proceeds of approximately $26 million to […]
(NASDAQ:MPLT), SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) — MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing Phase 2 ZEPHYR and IRIS clinical studies, which are progressing ahead of schedule. The company's Phase 2 ZEPHYR trial evaluating ML-007C-MA for the treatment
(TSX-V:VRR),(Boerse Frankfurt – Freiverkehr:5VR.F),(Boerse Frankfurt – Freiverkehr:5VR), NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 09, 2026 (GLOBE NEWSWIRE) — VR Resources Limited (“VR” or the “Company“, TSXV: VRR) announces that due to significant investor demand, it has increased the size of its
(NASDAQ:ATHA),(NASDAQ:LONA), BOTHELL, Wash., Jan. 09, 2026 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it has changed its name to LeonaBio, Inc. The name change aligns with the Company's transformative acquisition of rights to
(TSX-V:NBLC),(OTC US:NBTRF),(Other OTC:NBTRF), THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Jan. 09, 2026 (GLOBE NEWSWIRE) — Nobel Resources Corp. (TSX-V: NBLC; OTCQB: NBTRF) (the “Company” or “Nobel“) announces a non-brokered private placement financing
(NYSE MKT:CATX), Updated interim results with an additional ~13 weeks of follow-up since the prior update [212Pb]VMT-α-NET continues to be well-tolerated Updated efficacy analysis suggests durable disease control and deepening of tumor response per RECIST v1.1 in the first 23 patients in Cohort 2 and both patients in Cohort 1 Objective response in 39% of
(NYSE:HRB), KANSAS CITY, Mo., Jan. 09, 2026 (GLOBE NEWSWIRE) — H&R Block (NYSE: HRB) today announced it will include Tax Pro Review services at no additional cost in its paid DIY online tax products for new clients through February 15. This offer supports digital-first filers while leveraging the company's 70-year legacy of professional tax expertise.
(NasdaqGM:AQST), Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency's review of Anaphylm NDA application is ongoing and no final FDA decision has been made Progresses global regulatory expansion activities in Canada, Europe, and the United Kingdom for Anaphylm
IRVINE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) — iHerb Holdings, LLC, one of the world's largest online retailers specializing in health and wellness, today announced that it has completed its acquisition of Vitacost.com, Inc. (“Vitacost”) from The Kroger Co. (“Kroger”). This acquisition is expected to significantly accelerate iHerb's market presence in the U.S. and firmly
DUBAI, United Arab Emirates, Jan. 09, 2026 (GLOBE NEWSWIRE) — Presales rarely stay quiet once momentum builds. When demand keeps rising across multiple stages, later phases tend to move faster and attract more attention. That is exactly what is happening with Mutuum Finance (MUTM). Since early 2025, the project has recorded steady growth rather than